Literature DB >> 11313865

p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin.

V Jaks1, A Jõers, A Kristjuhan, T Maimets.   

Abstract

In this study we characterize the connections between p53-dependent G1 cell cycle arrest, transcriptional activation of the protein and the increase of its intracellular steady-state concentration. Several cell lines expressing wild-type p53 protein were treated with increasing concentrations of DNA-damaging drug camptothecin. Lower doses of the drug caused transcriptional activation of p53, but no accumulation of the protein was detected. Only after a certain threshold dose of camptothecin does the amount of the protein rapidly increase and reach its plateau levels. The threshold dose was different for different cell lines, but the general non-linear profile was similar. Increase of p53 level was accompanied by additional transcriptional activation of some p53 target genes (i.e. waf1), but not the others (mdm2). We demonstrate here that transcriptional activation of p53 after the treatment of camptothecin is not sufficient to cause p53-dependent G1 cell cycle arrest. The latter is observable only after the increase of steady-state level of p53. Low drug concentrations, although accompanied by transcriptional activation of p53, do not cause either p53 protein accumulation nor cell cycle arrest at G1. We propose a model for p53 acting as a part of cellular sensor system detecting the severity of DNA damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313865     DOI: 10.1038/sj.onc.1204232

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Replication of damaged DNA in vitro is blocked by p53.

Authors:  Jianmin Zhou; Carol Prives
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways.

Authors:  Jérôme Barbier; Martin Dutertre; Danielle Bittencourt; Gabriel Sanchez; Lise Gratadou; Pierre de la Grange; Didier Auboeuf
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

3.  Perturbation Detection Through Modeling of Gene Expression on a Latent Biological Pathway Network: A Bayesian hierarchical approach.

Authors:  Lisa M Pham; Luis Carvalho; Scott Schaus; Eric D Kolaczyk
Journal:  J Am Stat Assoc       Date:  2016-05-05       Impact factor: 5.033

4.  Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.

Authors:  Elena Tassi; Marina Zanon; Claudia Vegetti; Alessandra Molla; Ilaria Bersani; Valentina Perotti; Marzia Pennati; Nadia Zaffaroni; Michele Milella; Soldano Ferrone; Carmelo Carlo-Stella; Alessandro M Gianni; Roberta Mortarini; Andrea Anichini
Journal:  Clin Cancer Res       Date:  2012-05-02       Impact factor: 12.531

5.  The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes.

Authors:  Suman Jayadev; Bomy Yun; Huy Nguyen; Hideaki Yokoo; Richard S Morrison; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-20       Impact factor: 4.147

6.  Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.

Authors:  A Zajkowicz; D Butkiewicz; A Drosik; M Giglok; R Suwiński; M Rusin
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.